Malignant News and Research

RSS
Reinforcement learning improves performance of AI-based skin cancer diagnosis

Reinforcement learning improves performance of AI-based skin cancer diagnosis

New gene editing approach could revolutionize the treatment of blood disorders

New gene editing approach could revolutionize the treatment of blood disorders

Researchers discover potential new treatment for rhabdomyosarcoma

Researchers discover potential new treatment for rhabdomyosarcoma

A novel pharmacology modeling approach to monitor acute lymphoblastic leukemia treatment

A novel pharmacology modeling approach to monitor acute lymphoblastic leukemia treatment

Research reveals therapeutic potential of novel compound in inhibiting oncogene translation

Research reveals therapeutic potential of novel compound in inhibiting oncogene translation

Six new Damon Runyon Clinical Investigators announced for 2023

Six new Damon Runyon Clinical Investigators announced for 2023

Routine next-generation sequencing can identify BRAF mutations in synovial sarcoma

Routine next-generation sequencing can identify BRAF mutations in synovial sarcoma

Breast cancer and MEN1: exploring the connection

Breast cancer and MEN1: exploring the connection

Healthy breast fat may protect against invasive breast cancer

Healthy breast fat may protect against invasive breast cancer

Study examines the link between oropharyngeal cancer and high-risk sexual behavior

Study examines the link between oropharyngeal cancer and high-risk sexual behavior

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Research offers hope for patients with lower lip sensory loss

Research offers hope for patients with lower lip sensory loss

Researchers develop 3D bioprinting technology for eliminating cancer cells

Researchers develop 3D bioprinting technology for eliminating cancer cells

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

REDH database provides insights into RNA editing in hematopoietic cells

REDH database provides insights into RNA editing in hematopoietic cells

High tumor monocyte content linked to better outcomes for esophageal cancer patients

High tumor monocyte content linked to better outcomes for esophageal cancer patients

Study traces the natural evolution of earliest stages of human cancers

Study traces the natural evolution of earliest stages of human cancers

AI tool can rapidly decode brain tumor DNA during surgery

AI tool can rapidly decode brain tumor DNA during surgery

Researchers show how communication networks in the tumor microenvironment promote cancer growth

Researchers show how communication networks in the tumor microenvironment promote cancer growth

Aneuploidy could function as a therapeutic target for cancer

Aneuploidy could function as a therapeutic target for cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.